Teladoc Health, Inc. (TDOC)

Teladoc Health Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	1,124	918.18	893.48	733.32	514.35
Short-Term Investments	0	0	2.54	53.25	2.71
Cash & Cash Equivalents	1,124	918.18	896.02	786.57	517.06
Cash Growth	22.38%	2.47%	13.91%	52.12%	8.05%
Receivables	217.42	210.55	168.96	169.28	56.95
Inventory	29.51	56.34	73.08	56.5	0
Other Current Assets	118.44	130.31	87.39	47.26	13.99
Total Current Assets	1,489	1,315	1,225	1,060	588
Property, Plant & Equipment	72.09	71.47	74.01	75.2	36.75
Goodwill and Intangibles	2,751	2,910	16,414	16,602	971.53
Other Long-Term Assets	80.26	48.54	20.7	18.36	6.55
Total Long-Term Assets	2,903	3,030	16,509	16,696	1,015
Total Assets	4,392	4,345	17,735	17,755	1,603
Accounts Payable	43.64	47.69	47.26	46.03	9.08
Deferred Revenue	109.28	113.79	79.4	54.81	14.77
Current Debt	0	0	13.31	56.01	0
Other Current Liabilities	267.7	238.29	191.04	175.8	66.34
Total Current Liabilities	420.62	399.77	331.01	332.65	90.18
Long-Term Debt	1,582	1,573	1,277	1,433	465.4
Other Long-Term Liabilities	64.16	64.51	81.1	106.17	33.22
Total Long-Term Liabilities	1,646	1,638	1,358	1,539	498.62
Total Liabilities	2,066	2,038	1,689	1,871	588.8
Total Debt	1,582	1,573	1,290	1,489	465.4
Debt Growth	0.52%	21.96%	-13.34%	219.87%	12.23%
Retained Earnings	-15,228.66	-15,008.29	-1,421.45	-992.66	-507.53
Comprehensive Income	-36.99	-42.78	-6.29	18.52	-17.24
Shareholders' Equity	2,326	2,308	16,046	15,884	1,014
Net Cash / Debt	-457.85	-655.15	-394.03	-702.1	51.66
Net Cash / Debt Growth	-	-	-	-	-19.09%
Net Cash Per Share	-2.78	-4.06	-2.51	-7.76	0.72
Working Capital	1,068	915.62	894.43	726.96	497.82
Book Value Per Share	14.13	14.29	102.24	175.49	14.11

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).